NeoMetacin: A Novel Anti-Cancer Drug Targeting Glycolysis Abstract Cancer is a complex disease characterized by uncontrolled cell growth and metastasis. Current treatments often have limitations in terms of efficacy and side effects. Therefore, there is a pressing need for novel therapeutic strategies. This research paper presents NeoMetacin, a potential anti-cancer drug targeting glycolysis, a metabolic… Continue reading NeoMetacin: A Novel Anti-Cancer Drug Targeting Glycolysis